Outcomes of MR-guided stereotactic radiotherapy (SBRT) or yttrium-90 transarterial radioembolization for hepatocellular carcinoma treated at an urban liver transplant center.”
Date
09/01/2021Abstract
Virtual Poster presented at: American Radium Society (ARS) 103rd Annual Meeting; Lahaina, HI.